导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 50.53% | 35/1050 |
| 近一周 | -3.44% | 896/1104 |
| 近一月 | -4.15% | 546/1102 |
| 近一季 | -6.66% | 680/1092 |
| 近半年 | 46.71% | 18/1070 |
| 近一年 | 57.71% | 44/1018 |
| 近两年 | 296.41% | 12/926 |
| 近三年 | 229.23% | 9/833 |
| 成立以来 | 297.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.14% 496/1070 |
103.37% 31/1101 |
- - |
- - |
| 2025 | 73.68% 54/1065 |
9.15% 176/1014 |
-5.71% 974/1038 |
65.04% 22/1050 |
2.25% 285/1065 |
| 2024 | 26.07% 42/1011 |
-11.43% 811/960 |
4.34% 123/983 |
13.04% 379/991 |
20.68% 13/1011 |
| 2023 | -1.61% 128/952 |
15.47% 50/880 |
9.30% 21/895 |
-19.00% 847/915 |
-3.76% 388/952 |
| 2022 | -13.52% 143/867 |
-21.56% 610/773 |
19.08% 30/806 |
0.77% 13/845 |
-8.13% 738/867 |
| 2021 | 7.45% 273/740 |
-7.34% 433/580 |
21.32% 143/659 |
-5.61% 372/704 |
1.27% 385/740 |
| 2020 | 44.98% 268/554 |
-8.85% 367/419 |
21.88% 252/466 |
10.59% 238/517 |
18.00% 156/554 |
| 2019 | 39.39% 226/410 |
20.38% 910/1149 |
2.34% 147/1231 |
1.10% 303/390 |
11.91% 112/410 |
| 2018 | -32.32% 247/349 |
- - |
- - |
- - |
-9.63% 268/1080 |
| 2017 | 34.28% 24/285 |
- - |
- - |
- - |
- - |
| 2016 | -29.14% 145/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 富国新兴产业股票A VS. 东吴新产业精选股票A(580008) |